Introduction: Obstructive sleep apnea-hypopnea syndrome (OSAHS) is an emerging public health concern. Although different treatments for OSAHS had been proposed, continuous positive airway pressure (CPAP) is the first-line treatment in moderate to serious OSAHS in which success can be achieved by increasing compliance to CPAP.

Materials And Methods: This study analyzes long-term CPAP compliance in patients with OSAHS on CPAP therapy for at least 1 month, who began CPAP therapy between January 2004 and December 2006, followed up at a Portuguese Sleep Outpatient Clinic in Santo António Hospital. Only effective data of CPAP use had been considered. During the first year of CPAP therapy, 96 patients were enrolled and followed up, but 15 patients had discontinued CPAP treatment. CPAP was used on average 5.1 h per day and in 80.1% of the total follow-up days. When compliance is defined as the use of CPAP for a minimum of 4 h per day in at least 70% of the follow-up days, only 54% of patients were classified as compliants during the first year.

Results And Conclusion: No statistically significant differences were found throughout the first year (p > 0.05) in terms of the percentage of compliants, controlling for demographic and clinic variables. None of the demographic and clinical baseline variables studied were found to be significant predictor of CPAP compliance (p > 0.05). This study diagnosed a low compliance to CPAP therapy in the studied sample, warning to the need of developing further studies in this area and to the need of implementing strategies to increase CPAP compliance.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11325-011-0542-9DOI Listing

Publication Analysis

Top Keywords

cpap therapy
16
cpap
12
cpap compliance
12
continuous positive
8
positive airway
8
airway pressure
8
obstructive sleep
8
follow-up days
8
compliance
7
therapy
5

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!